drugset / Trial / NCT01171664

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects

NCT01171664 ↗

Phase 2 Completed 100 enrolled Magna Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To report and compare total symptom scores, nasal symptom scores, post-nasal drip symptom scores, and adverse reactions in and between SAR subjects on active drug and SAR subjects on placebo.

Timeline

Start
2010-09
Primary completion
2010-10
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject STAHIST Unknown — —